Frequency Of Elevated Troponin T In Patients Of Hronic Renal Failure Without Clinically Suspected Acute Myocardial

Syed Affan Ali1, Sumera Kazmi1, Mir Jalal-Ud-Din2

  • 1Department of Medicine, Abbottabad International Medical College, Abbottabad, Pakistan.

Insights

Elevated Troponin T is common in chronic renal failure (CRF) patients without acute myocardial infarction, with nearly 40% showing higher levels. This elevation is significantly linked to the stage of kidney disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Biochemistry

Background:

  • Cardiac Troponins are key indicators of myocardial injury.
  • Elevated Troponin T levels can occur in chronic renal failure (CRF) patients independent of acute myocardial infarction.
  • Understanding Troponin T elevation in CRF is crucial for accurate diagnosis.

Purpose of the Study:

  • To determine the frequency of elevated Troponin T in CRF patients without clinically suspected acute myocardial infarction.
  • To investigate the association between elevated Troponin T and the stage of chronic renal failure.

Main Methods:

  • A cross-sectional study involving 117 CRF patients was conducted.
  • Patients with other causes of elevated Troponin T (e.g., ischemia, sepsis, heart failure, cardiotoxic chemotherapy) were excluded.
  • Glomerular filtration rate (GFR) was estimated to define and stage CRF.

Main Results:

  • Out of 117 participants, 45 (38.5%) had elevated Troponin T.
  • A significant association was observed between the stage of CRF and elevated Troponin T levels.
  • A statistically significant negative correlation (r=-0.213, p=0.021) was found between GFR and serum Troponin T levels.

Conclusions:

  • A high proportion of chronic renal failure patients exhibit elevated Troponin T.
  • The elevation of Troponin T in CRF patients is significantly associated with the stage of renal failure.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
805
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
222
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
830
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
322
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
370